156 related articles for article (PubMed ID: 11484279)
1. [The role of low molecular weight heparin (fragmin) in the prophylaxis and treatment of venous thromboembolism in major abdominal operations].
Khinev S; Tsoneva D; Darfinova K; Kamenova B; Yar'mov N
Khirurgiia (Sofiia); 2000; 56(2):14-6. PubMed ID: 11484279
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
Couturaud F; Julian JA; Kearon C
Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of venous thromboembolism in internal medicine and neurology].
Malý J; Dulícek P; Penka M; Malý R; Gumulec J
Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparins are essentially the same for treatment and prevention of venous thromboembolism.
Lopez LM
Pharmacotherapy; 2001 Jun; 21(6 Pt 2):56S-61S; discussion 71S-72S. PubMed ID: 11401194
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparins in clinical practice.
Hunt D
South Med J; 1998 Jan; 91(1):2-10. PubMed ID: 9438394
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
[TBL] [Abstract][Full Text] [Related]
8. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
Monreal M; Lafoz E; Olive A; del Rio L; Vedia C
Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649
[TBL] [Abstract][Full Text] [Related]
9. Outpatient treatment of pulmonary embolism with dalteparin.
Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
[TBL] [Abstract][Full Text] [Related]
10. Dalteparin: pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic diseases.
Pineo GF; Hull RD
Eur J Med Res; 2004 Apr; 9(4):215-24. PubMed ID: 15210402
[TBL] [Abstract][Full Text] [Related]
11. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
Ruiz Manzano J; Monreal M
Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
[No Abstract] [Full Text] [Related]
12. [Low-molecular weight heparins in the prophylaxis and treatment of pulmonary thromboembolism].
Borja J; Olivella P
Rev Esp Cardiol; 2001 Sep; 54(9):1121-2. PubMed ID: 11535193
[No Abstract] [Full Text] [Related]
13. [Prevention of venous thromboembolism in surgery, in laparoscopic surgery, in venous surgery and in urology].
Gumulec J; Penka M; Bezdĕk R; Czudek S; Stursa M; Wróbel M; Brejcha M; Klodová D; Sumná E; Králová S
Vnitr Lek; 2006 Mar; 52 Suppl 1():41-50. PubMed ID: 16637449
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
Tran H; McRae S; Ginsberg J
Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
[TBL] [Abstract][Full Text] [Related]
15. [Heparin therapy: 1998 (current use of the 80-year-old heparin)].
Rák K
Orv Hetil; 1999 Jan; 140(2):59-66. PubMed ID: 9949661
[TBL] [Abstract][Full Text] [Related]
16. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery.
Epstein NE
Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995
[TBL] [Abstract][Full Text] [Related]
17. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
Hull RD; Pineo GF; Stein P
Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
Prandoni P; Simioni P; Pagnan A
Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
DeLoughery TG
Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
[TBL] [Abstract][Full Text] [Related]
20. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
